- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Senores Pharmaceuticals Limited — Updates, 27-07-2026: Press Release
27-07-2026 | 03:44 pm
27-07-2026 | 03:44 pm
Senores Pharmaceuticals reported robust financial results for the latest quarter: Revenue soared 36% to ₹180.2 Cr, EBITDA jumped 87% to ₹54 Cr, and PAT grew 56% to ₹31 Cr. Growth was fueled by Regulated Markets and an expanded product portfolio, boosted by a new USFDA-approved plant.
No comments yet. Be the first to comment!